BIIB News
Biogen Inc.
$232.83
+$3.93(+1.72%)
72
Overall
80
Value
91
Tech
47
Quality
Market Cap
$34.40B
Volume
1.95M
52W Range
$138.00 - $230.49
Target Price
$239.19
BIIB news: the latest Biogen Inc. headlines, press releases and market updates, newest first.
Latest BIIB News
- Piper Sandler Keeps Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?Ran Melamed · Oct 7, 2026
- Piper Sandler Keeps Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
- Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Biogen (BIIB)TipRanks Newsroom · Oct 2, 2026
- Biogen’s Salanersen Trial Strengthens Its SMA Pipeline OutlookTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)TipRanks Newsroom · Sep 25, 2026
- Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)TipRanks Newsroom · Sep 18, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $232.83 | +1.7% | 1.95M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |